Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT)

[1]  M. Henzlova,et al.  Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure. SOLVD Investigators. , 1995, The American journal of cardiology.

[2]  F. Yin,et al.  Relation between diurnal variation of blood pressure and left ventricular mass in a Chinese population. , 1995, The American journal of cardiology.

[3]  J. Cohn,et al.  Interobserver discordance in the classification of mechanisms of death in studies of heart failure. , 1995, Journal of cardiac failure.

[4]  M A Konstam,et al.  Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. , 1995, Journal of cardiac failure.

[5]  S. Yusuf,et al.  Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the studies of left ventricular dysfunctions (SOLVD) registry , 1993 .

[6]  M. Rousseau,et al.  Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators. , 1993, Circulation.

[7]  R. Bain,et al.  Effects of vesnarinone on morbidity and mortality in patients with heart failure , 1993 .

[8]  J. Cohn,et al.  Plasma Norepinephrine, Plasma Renin Activity, and Congestive Heart Failure Relations to Survival and the Effects of Therapy in V‐HeFT II , 1993, Circulation.

[9]  J. Cohn,et al.  Mechanism of Death in Heart Failure The Vasodilator‐Heart Failure Trials , 1993, Circulation.

[10]  B. Pitt,et al.  Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.

[11]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[12]  R. Soufer,et al.  Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. , 1992, The American journal of cardiology.

[13]  M. Luu,et al.  Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. , 1992, Journal of the American College of Cardiology.

[14]  M. Packer.  Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. , 1992, Circulation.

[15]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[16]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[17]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[18]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[19]  J. Kjekshus.  Arrhythmias and mortality in congestive heart failure. , 1990, The American journal of cardiology.

[20]  J. Cohn,et al.  Heart failure with normal ejection fraction. The V-HeFT study , 1990 .

[21]  M. Weir,et al.  The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .

[22]  B. Pitt,et al.  Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.

[23]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[24]  M. Wilén,et al.  Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. , 1988, JAMA.

[25]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[26]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .

[27]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[28]  M. Nicholls,et al.  Effect of enalapril on ventricular arrhythmias in congestive heart failure. , 1985, The American journal of cardiology.

[29]  B. W. East,et al.  Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. , 1985, British heart journal.

[30]  H. Sostman,et al.  Intact systolic left ventricular function in clinical congestive heart failure. , 1985, The American journal of cardiology.

[31]  B. W. East,et al.  Captopril in heart failure. A double blind controlled trial. , 1984, British heart journal.

[32]  R. Myerburg,et al.  Congestive heart failure: echocardiographic insights. , 1983, The American journal of medicine.

[33]  E. Freis,et al.  Direct and reflex cardiostimulating effects of hydralazine. , 1977, The American journal of cardiology.

[34]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[35]  D. Cox.  Regression Models and Life-Tables , 1972 .